Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma

Journal of Investigative Dermatology

Volumn 127, Issue 2, 2007, Pages 281-292

  Zhou, Lixin ^a   Askew, David ^a   Wu, Caiyun ^a   Gilliam, Anita C ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; MESSENGER RNA; NERVE GROWTH FACTOR BETA SUBUNIT; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CELL ISOLATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCLERODERMA; SKIN FIBROSIS;

ANIMALS; CELL ADHESION MOLECULES; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SCLERODERMA, LOCALIZED; SKIN; T-LYMPHOCYTES;

EID: 33846188950     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700517     Document Type: Article

References (26)

1. Ahmed S, Tan F (2003) Identification of novel targets in scleroderma. Update on population studies, cDNA arrays, SNP analysis, and mutations. Curr Opin Rheumatol 15:766-74
2. Atamas S, White B (2003) The role of chemokines in the pathogenesis of scleroderma. Curr Opin Rheumatol 15:772-7
3. Baggiolini M (2003) Chemokines and leukocyte traffic. Nature 392:565-568
4. Campbell J, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P et al. (1999) The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776-80
5. Denton C, Abraham D (2004) Transgenic analysis of scleroderma: understanding key pathogenic events in vivo. Autoimmun Rev 3:285-93
6. Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181-91
7. Distler O, Pap T, Kowal-Bielecka O, Meyringer R, Guiducci S, Landthaler M et al. (2001) Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 44:2665-78
8. Ferrara J, Cooke K, Teshima T (2003) The pathophysiology of acute graft-versus-host disease. Int J Hematol 78:181-7
9. Fleischmajer R (1977) The pathophysiology of scleroderma. Int J Dermatol 16:310-8
10. Ghosh AK, Yuan W, Mori Y, Chen S, Varga J (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 276:11041-8
11. Gilliam A (2004) Experimental Mouse Models for Scleroderma. CRC Press: Boca Raton, FL, pp 517-534
12. Hu H, Li G, Lim Y, Chan S, Yap E (1999) Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease. Immunology 98:379-92
13. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki MOY (1996) Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 217:21514-21
14. Kahaleh M, LeRoy E (1999) Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 31:195-214
15. Kielty CM, Raghanath M, Siracusa LD, Sherratt MJ, Peters R, Shuttleworth CA et al. (1998) The tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils. J Cell Biol 140:1159-66
16. Kim C, Kunkel E, Boisvert J, Johnston B, Campbell J, Genovese M et al. (2001) Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 107:595-601
17. Kluger M (2004) Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv Dermatol 20:163-201
18. McCormick LL, Zhang Y, Tootell E, Gilliam AC (1999) Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 163:5693-9
19. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino M, Bendtzen K et al. (2002) Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-21
20. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A et al. (2002) Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 161:195-206
21. Sakkas L (2005) New developments in the pathogenesis of systemic sclerosis. Autoimmunity 38:113-6
22. Schon M, Zollner T, Boehncke W (2003) The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. J Invest Dermatol 121:951-62
23. Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ et al. (1996) A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 6:300-13
24. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen C (2000) A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115:640-8
25. Wysocki C, Burkett S, Panoskaltsis-Mortari A, Kirby S, Luster A, McKinnon K et al. (2004) Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol 173:845-54
26. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC (2002) Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 168:3088-98